NO20016232L - Amorfe salpetersyre-estere og farmasöytiske preparater inneholdene disse - Google Patents

Amorfe salpetersyre-estere og farmasöytiske preparater inneholdene disse

Info

Publication number
NO20016232L
NO20016232L NO20016232A NO20016232A NO20016232L NO 20016232 L NO20016232 L NO 20016232L NO 20016232 A NO20016232 A NO 20016232A NO 20016232 A NO20016232 A NO 20016232A NO 20016232 L NO20016232 L NO 20016232L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
compositions containing
nitric esters
amorphous
amorphous nitric
Prior art date
Application number
NO20016232A
Other languages
English (en)
Other versions
NO20016232D0 (no
NO321523B1 (no
Inventor
Francesca Benedini
Patrizia Antognazza
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of NO20016232D0 publication Critical patent/NO20016232D0/no
Publication of NO20016232L publication Critical patent/NO20016232L/no
Publication of NO321523B1 publication Critical patent/NO321523B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00—Esters of nitric or nitrous acid
    • C07C203/02—Esters of nitric acid
    • C07C203/04—Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
NO20016232A 1999-06-24 2001-12-19 Preparat omfattende et nitroksyderivat, farmasoytisk formulering inneholdende dette og fremgangsmate for fremstilling av preparatet. NO321523B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001402A IT1312115B1 (it) 1999-06-24 1999-06-24 Composti amorfi e relative composizioni farmaceutiche
PCT/EP2000/005723 WO2001000563A1 (en) 1999-06-24 2000-06-21 Amorphous nitric esters and their pharmaceutical compositions

Publications (3)

Publication Number Publication Date
NO20016232D0 NO20016232D0 (no) 2001-12-19
NO20016232L true NO20016232L (no) 2001-12-19
NO321523B1 NO321523B1 (no) 2006-05-15

Family

ID=11383219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016232A NO321523B1 (no) 1999-06-24 2001-12-19 Preparat omfattende et nitroksyderivat, farmasoytisk formulering inneholdende dette og fremgangsmate for fremstilling av preparatet.

Country Status (23)

Country Link
US (1) US6753442B1 (no)
EP (1) EP1187803B1 (no)
JP (1) JP2003503380A (no)
KR (1) KR100672001B1 (no)
CN (1) CN1187312C (no)
AT (1) ATE302746T1 (no)
AU (1) AU781479B2 (no)
BR (1) BR0011831A (no)
CA (1) CA2377132A1 (no)
DE (1) DE60022188T2 (no)
DK (1) DK1187803T3 (no)
ES (1) ES2246878T3 (no)
HU (1) HUP0201721A3 (no)
IL (1) IL146789A0 (no)
IT (1) IT1312115B1 (no)
MX (1) MXPA01013273A (no)
NO (1) NO321523B1 (no)
NZ (1) NZ515757A (no)
PL (1) PL195557B1 (no)
RU (1) RU2248963C2 (no)
TR (1) TR200103624T2 (no)
WO (1) WO2001000563A1 (no)
ZA (1) ZA200109862B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
DE60122939T2 (de) 2000-12-21 2007-01-11 Nitromed, Inc., Bedford Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren
EP1219306A1 (en) * 2000-12-29 2002-07-03 Nicox S.A. Compositions comprising cyclodextrins and NO- releasing drugs
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
US7163958B2 (en) 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
CA2493156A1 (en) 2002-07-29 2004-02-05 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
DE602004000260T2 (de) 2003-07-22 2006-08-24 Arena Pharmaceuticals, Inc., San Diego Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
WO2009023253A2 (en) 2007-08-15 2009-02-19 Arena Pharmaceuticals Inc. IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
EA027333B1 (ru) 2007-10-17 2017-07-31 Тодд Ф. Овокайтис Стабильный при комнатной температуре некристаллический аспирин
EA023338B1 (ru) * 2007-10-17 2016-05-31 Тодд Ф. Овокайтис Способ модификации твердого состояния соединения и соаморфные композиции, полученные этим способом
ES2324007A1 (es) * 2007-10-25 2009-07-28 Ferrer Internacional, S.A. Una forma amorfa de un compuesto antiinflamatorio.
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
ES2666324T3 (es) * 2008-10-28 2018-05-04 Arena Pharmaceuticals, Inc. Composiciones de un modulador del receptor de serotonina 5-HT2A útiles para el tratamiento de trastornos relacionados con el mismo
WO2010062321A1 (en) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
EP2344592B1 (en) 2008-11-04 2014-12-17 DSM IP Assets B.V. D 1413 ht radiation curable coatings for optical fiber
US10202598B2 (en) 2014-05-30 2019-02-12 Todd Frank Ovokaitys Methods and systems for generation, use, and delivery of activated stem cells
WO2015187974A1 (en) 2014-06-06 2015-12-10 Ovokaitys Todd Frank Methods and compositions for increasing the bioactivity of nutrients
US10384985B2 (en) 2014-06-06 2019-08-20 B.K. Consultants, Inc. Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants
JP2018516992A (ja) 2015-06-12 2018-06-28 アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
RU2018103338A (ru) 2015-07-15 2019-08-15 Аксовант Сайенсиз Гмбх Производные диарил- и арилгетероарилмочевины для профилактики и лечения галлюцинаций, ассоциированных с нейродегенеративным заболеванием

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243367B (it) * 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
IT1256345B (it) * 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
IT1256450B (it) 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
RU2145595C1 (ru) 1994-05-10 2000-02-20 Никокс С.А. Нитроксисоединения и фармацевтическая композиция на их основе, имеющие противовоспалительную, анальгетическую и антитромбоцитарную активности
IT1276071B1 (it) * 1995-10-31 1997-10-24 Nicox Ltd Compositi ad attivita' anti-infiammatoria
KR19990001564A (ko) * 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
IT1307928B1 (it) 1999-01-26 2001-11-29 Nicox Sa Metodo di sintesi di nitrossimetilfenil esteri di derivatidell'aspirina.

Also Published As

Publication number Publication date
NO20016232D0 (no) 2001-12-19
AU6264400A (en) 2001-01-31
PL195557B1 (pl) 2007-10-31
HUP0201721A3 (en) 2003-08-28
KR100672001B1 (ko) 2007-01-19
JP2003503380A (ja) 2003-01-28
ZA200109862B (en) 2003-05-28
ITMI991402A1 (it) 2000-12-24
DE60022188D1 (de) 2005-09-29
EP1187803A1 (en) 2002-03-20
CA2377132A1 (en) 2001-01-04
TR200103624T2 (tr) 2002-04-22
DE60022188T2 (de) 2006-06-08
AU781479B2 (en) 2005-05-26
ES2246878T3 (es) 2006-03-01
CN1356975A (zh) 2002-07-03
DK1187803T3 (da) 2005-11-28
BR0011831A (pt) 2002-03-19
KR20020008220A (ko) 2002-01-29
ATE302746T1 (de) 2005-09-15
IL146789A0 (en) 2002-07-25
IT1312115B1 (it) 2002-04-04
RU2248963C2 (ru) 2005-03-27
US6753442B1 (en) 2004-06-22
MXPA01013273A (es) 2003-07-14
NZ515757A (en) 2004-02-27
NO321523B1 (no) 2006-05-15
PL352529A1 (en) 2003-08-25
HUP0201721A2 (en) 2002-10-28
EP1187803B1 (en) 2005-08-24
CN1187312C (zh) 2005-02-02
WO2001000563A1 (en) 2001-01-04
ITMI991402A0 (it) 1999-06-24

Similar Documents

Publication Publication Date Title
NO20016232D0 (no) Amorfe salpetersyre-estere og farmasöytiske preparater inneholdene disse
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
IS6254A (is) Lyfjasamsetningar sem innihalda HMG afoxunarensímlata
CY2016013I2 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν βαλσαρτανη και αναστολεις nep
HUP0302412A3 (en) Betha-carboline derivatives useful as inhibitors of phosphodiesterase and pharmaceutical compositions containing the same
DE69907977D1 (de) Pyrrolobenzodiazepine
CY1108522T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
IL133831A0 (en) Pharmaceutical compositions containing proteasome inhibitors
HUP0105113A3 (en) Benzoheterocycles and their use as mek inhibitors and pharmaceutical compositions containing the compounds
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
HUP0302922A3 (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation and pharmaceutical compositions containing them
HUP0202938A3 (en) N-aryl-2-sulfonamidobenzamides as phosphate transport inhibitors and pharmaceutical compositions containing them
NO20034778D0 (no) Farmasöytiske sammensetninger for oral og topisk anvendelse
HUP0401504A3 (en) Substituted azole karboxylic acid derivatives useful as antidiabetic and antiobesity agents and pharmaceutical compositions containing them
NO20035599D0 (no) Deutererte N-substituerte og <alfa>-substituerte difenylalkoksyeddiksyreaminoalkylestere og medikamenter inneholdende disse
IL169163A0 (en) Optically active dihydropyridine derivative and pharmaceutical compositions containing the same
HUP0302397A3 (en) Heterocyclic compounds and pharmaceutical compositions containing them
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DK0508334T3 (da) Aminophenolderivater og farmaceutiske præparater indeholdende disse
DK1005342T3 (da) Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid
EE200200032A (et) Interleukiin-18 inhibiitorite kasutamine metastaaside pärssimiseks sobivate ravimite valmistamiseksning selliseid inhibiitoreid sisaldav farmatseutiline kompositsioon
IS6140A (is) Lyfjablanda sem inniheldur hemil karboxýpeptíðasaU og þrombínhemil
DK1263719T3 (da) N-deacetylthiocolchin-derivater og farmaceutiske sammensætninger indeholdende disse.
NO20014988D0 (no) Pseudomycinantisoppsammensetninger og fremgangsmåter for anvendelser av disse
DK1156829T3 (da) Stabil formulering indeholdende fumagillin